Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against KaloBios Pharmaceuticals, Inc.
(firmenpresse) - OKLAHOMA CITY, OK -- (Marketwired) -- 12/22/15 -- On December 18, 2015, a class action lawsuit was filed in the United States District Court for the Northern District of California against KaloBios Pharmaceuticals, Inc. (NASDAQ: KBIO). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is November 19, 2015 through December 17, 2015.
Plaintiff seeks to recover damages on behalf of all KaloBios Pharmaceuticals, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above. You may move the Court no later than Tuesday, February 16, 2016 to serve as a lead plaintiff for the entire Class. However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.
If you wish to discuss this action, obtain further information and participate in this or any other securities litigation, or should you have any questions or concerns regarding this notice or preservation of your rights, please contact:
Robin Hester
FEDERMAN & SHERWOOD
10205 North Pennsylvania Avenue
Oklahoma City, OK 73120
Email to:
Or, visit the firm''s website at
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 22.12.2015 - 12:02 Uhr
Sprache: Deutsch
News-ID 1406063
Anzahl Zeichen: 2379
contact information:
Contact person:
Town:
OKLAHOMA CITY, OK
Phone:
Kategorie:
Alternative
Typ of Press Release:
type of sending:
Date of sending:
Anmerkungen:
Diese Pressemitteilung wurde bisher 334 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against KaloBios Pharmaceuticals, Inc.
"
steht unter der journalistisch-redaktionellen Verantwortung von
Federman & Sherwood (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
